Package Leaflet: Information for the User
gabapentina cinfa 600 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
gabapentina cinfa belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long-lasting pain caused by damage to the nerves).
The active substance of gabapentina cinfa is gabapentin. Gabapentin is used to treat:
You or your child aged 6 years or older should take gabapentina in combination with your current treatment unless otherwise indicated. Gabapentina can also be given as the only medicine in the treatment of adults and children over 12 years of age.
Peripheral neuropathic pain (long-lasting pain caused by damage to the nerves). There are various diseases that can cause peripheral neuropathic pain (mainly in legs and/or arms), such as diabetes or herpes. The sensation of pain can be described as heat, burning, throbbing, shooting, stabbing, acute, spasms, continuous, tingling, numbness, and a feeling of pins and needles, etc.
Do not take gabapentina cinfa
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before taking gabapentina cinfa
There have been reports of abuse and dependence on gabapentina from post-marketing experience. Talk to your doctor if you have a history of abuse or dependence.
A small number of people being treated with antiepileptics such as gabapentina have had thoughts of harming themselves or suicide. If at any time you have these thoughts, contact your doctor as soon as possible.
Dependence
Some people may develop dependence (need to continue taking the medicine) on gabapentina cinfa. They may experience withdrawal symptoms when they stop taking gabapentina cinfa (see section 3, "How to take gabapentina cinfa" and "If you stop taking gabapentina cinfa"). If you are concerned about becoming dependent on gabapentina cinfa, it is important that you talk to your doctor.
If you experience any of the following signs while taking gabapentina cinfa, it may be indicative of dependence.
If you notice any of the above, talk to your doctor to decide what the best course of treatment is for you, including when it is appropriate to stop treatment and how to do it safely.
Important information about potentially serious reactions
Severe skin reactions have been reported with the use of gabapentina, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug rash with eosinophilia and systemic symptoms (DRESS). Stop taking gabapentina and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
Read the description of these symptoms in section 4 of this leaflet"Contact your doctor immediately if you experience any of the following symptoms after taking this medicine as they can be serious".
Muscle weakness, tenderness, or pain on palpation, and especially if you feel unwell or have a fever, could be due to abnormal breakdown of muscle fibers, which can lead to kidney problems and put your life at risk. You may also experience discoloration of the urine and changes in blood test results (significant increase in creatine phosphokinase in the blood). If you experience any of these signs or symptoms, please contact your doctor immediately.
Other medicines and gabapentina cinfa
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. In particular, tell your doctor (or pharmacist) if you are taking or have recently taken any medicine for seizures, sleep disorders, depression, anxiety, or any other neurological or psychiatric problem.
Medicines containing opioids such as morphine
If you are taking any medicine that contains opioids (such as morphine), tell your doctor or pharmacist, as opioids can increase the effect of gabapentina. Additionally, the combination of gabapentina with opioids can cause symptoms such as drowsiness, sedation, decreased breathing, or death.
Antacids for indigestion
If you take gabapentina at the same time as antacids that contain aluminum and magnesium, the absorption of gabapentina in the stomach may be reduced. Therefore, it is recommended that gabapentina be taken at least 2 hours after taking an antacid.
Gabapentina:
Taking gabapentina cinfa with food
Gabapentina can be taken with or without food.
Pregnancy, breast-feeding, and fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Do not take gabapentina during pregnancy, unless your doctor has told you to. An effective contraceptive method should be used in women of childbearing age.
There are no specific studies of the use of gabapentina in pregnant women, but in the case of other medicines used to treat seizures, there have been reports of an increased risk of harm to the developing baby, particularly when more than one medicine is used to treat seizures. Therefore, whenever possible, you should try to take only one medicine for seizures during pregnancy and only under the advice of your doctor.
Contact your doctor immediately if you become pregnant, think you may be pregnant, or plan to become pregnant while taking gabapentina. Do not stop taking this medicine suddenly, as this may cause seizures to return, which could have serious consequences for you and your baby.
If you take gabapentina during pregnancy, gabapentina may cause withdrawal symptoms in newborns. This risk may be higher when gabapentina is taken with opioid painkillers (drugs for treating intense pain).
Breast-feeding
Gabapentin, the active substance of gabapentina cinfa, passes into breast milk. Breast-feeding is not recommended while taking gabapentina, as the effect on the baby is unknown.
Fertility
There are no effects on fertility in animal studies.
Driving and using machines
Gabapentina may cause symptoms such as drowsiness, dizziness, or changes in vision and reduce your reaction ability. These effects, as well as your own illness, may make it difficult for you to drive vehicles or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities that require special attention until your doctor assesses your response to this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist. Do not take more than the prescribed dose.
Your doctor will determine the dose that is right for you.
Epilepsy, the recommended dose is:
Adults and adolescents:
Take the number of tablets that your doctor has told you to. Normally, your doctor will gradually increase your dose. The initial dose will generally be 300 to 900 mg per day. From there, the dose may be increased as indicated by your doctor up to a maximum dose of 3600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
Children aged 6 years and older:
Your doctor will decide the dose to be given to your child based on the child's weight. The treatment will begin with a low initial dose that will be gradually increased over a period of approximately 3 days. The usual dose for controlling epilepsy is 25-35 mg per kg per day. The usual dose is administered by taking the tablets, divided into 3 equal doses per day, normally one in the morning, one at noon, and one at night.
Gabapentina is not recommended for use in children below 6 years of age.
Peripheral neuropathic pain, the recommended dose is:
Adults:
Take the number of tablets that your doctor has told you to. Normally, your doctor will gradually increase your dose. The initial dose will generally be 300 to 900 mg per day. From there, the dose may be increased as indicated by your doctor up to a maximum dose of 3600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
If you have kidney problems or are on hemodialysis
Your doctor may prescribe a different dosage regimen and/or different doses if you have kidney problems or are on hemodialysis.
If you are an elderly patient (over 65 years of age)
You should take the normal dose of gabapentina, unless you have kidney problems.
Your doctor may prescribe a different dosage regimen or different doses if you have kidney problems.
If you think that the effect of gabapentina is too strong or too weak, tell your doctor or pharmacist as soon as possible.
Method of administration
gabapentina cinfa is administered orally. Always swallow the tablets with a sufficient amount of water. The tablet can be divided into equal doses.
Continue taking gabapentina until your doctor tells you to stop.
If you take more gabapentina cinfa than you should
Doses higher than those recommended may cause an increase in side effects, including loss of consciousness, dizziness, double vision, slurred speech, numbness, and diarrhea. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken, or go to the emergency department of the nearest hospital if you take more gabapentina than your doctor prescribed. Bring any tablets that you have not taken, along with the packaging and the leaflet, so that the hospital can easily identify the medicine you have taken.
If you forget to take gabapentina cinfa
If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. Do not take a double dose to make up for forgotten doses.
If you stop taking gabapentina cinfa
Do not stop taking gabapentina cinfa suddenly. If you want to stop taking gabapentina cinfa, talk to your doctor first. Your doctor will tell you how to proceed. If you are going to stop treatment, it should be done gradually over a minimum of one week. You should be aware that you may experience certain side effects, called withdrawal symptoms, after stopping treatment with gabapentina cinfa after short or long-term use. These include seizures, anxiety, difficulty sleeping, feeling unwell (nausea), pain, sweating, tremors, headache, depression, abnormal sensation, dizziness, and a general feeling of being unwell. These effects usually occur within the first 48 hours after stopping treatment with gabapentina cinfa. If you experience this withdrawal syndrome, you should contact your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Contact your doctor immediatelyif you experience any of the following symptoms after taking this medicine, as they can be serious:
Contact your doctor immediately if you have any of the following symptoms:
These symptoms may be the first signs of a severe reaction. You should be examined by a doctor to decide if you should continue taking gabapentina.
Other adverse effects include:
Very common adverse effects (may affect more than 1 in 10 people)
Common adverse effects (may affect up to 1 in 10 people):
Additionally, in clinical trials in children, aggressive behavior and spasmodic movements were reported as common adverse effects.
Uncommon adverse effects (may affect up to 1 in 100 people)
Rare adverse effects (may affect up to 1 in 1,000 people)
Adverse effects of unknown frequency(cannot be estimated from available data)
You should know that you may experience certain adverse effects, called withdrawal syndrome, after interrupting short-term or long-term treatment with gabapentina cinfa (see "If you stop treatment with gabapentina cinfa").
Stop taking gabapentina cinfa and seek immediate medical attention if you notice any of these symptoms:
After the marketing of gabapentina cinfa,the following adverse effects have been reported:
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not store at a temperature above 30°C.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of gabapentina cinfa
The active ingredient is gabapentina. Each film-coated tablet contains 600 mg of gabapentina.
The other components are: Core: poloxamer, pregelatinized corn starch, copovidone, magnesium stearate, crospovidone. Coating: Opadry Y-1-7000 (hypromellose, titanium dioxide, and macrogol).
Appearance of the product and package contents
gabapentina cinfa 600 mg film-coated tablets are oblong, biconvex, scored tablets, white in color, and marked with the code “G1”.
They are available in PVC-PVDC/Aluminum blisters in packs of 90 tablets.
Marketing authorization holder and manufacturer
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra)- Spain
Date of the last revision of this prospectus:March 2023
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the prospectus and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/76215/P_76215.html
QR code to: https://cima.aemps.es/cima/dochtml/p/76215/P_76215.html
The average price of GABAPENTINA CINFA 600 MG FILM-COATED TABLETS in October, 2025 is around 18.45 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.